ACAD
Price
$18.42
Change
+$0.22 (+1.21%)
Updated
Mar 28, 1:54 PM EST
34 days until earnings call
RVMD
Price
$32.23
Change
+$0.51 (+1.61%)
Updated
Mar 28, 6:59 PM EST
39 days until earnings call
Ad is loading...

Analysis and predictions ACAD vs RVMD

Header iconACAD vs RVMD Comparison
Open Charts ACAD vs RVMDBanner chart's image
ACADIA Pharmaceuticals
Price$18.42
Change+$0.22 (+1.21%)
Volume$2.77K
CapitalizationN/A
Revolution Medicines
Price$32.23
Change+$0.51 (+1.61%)
Volume$606.6K
CapitalizationN/A
View a ticker or compare two or three
ACAD vs RVMD Comparison Chart

Loading...

ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RVMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ACAD vs. RVMD commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACAD is a Hold and RVMD is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ACAD: $18.49 vs. RVMD: $32.23)
Brand notoriety: ACAD and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACAD: 53% vs. RVMD: 44%
Market capitalization -- ACAD: $3B vs. RVMD: $5.22B
ACAD [@Biotechnology] is valued at $3B. RVMD’s [@Biotechnology] market capitalization is $5.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACAD’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • ACAD’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, ACAD is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACAD’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 4 bullish TA indicator(s).

  • ACAD’s TA Score: 4 bullish, 4 bearish.
  • RVMD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACAD and RVMD are a good buy in the short-term.

Price Growth

ACAD (@Biotechnology) experienced а +0.43% price change this week, while RVMD (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.78%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +88.40%.

Reported Earning Dates

ACAD is expected to report earnings on May 01, 2024.

RVMD is expected to report earnings on May 06, 2024.

Industries' Descriptions

@Biotechnology (+4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ACAD with price predictions.
OPEN
A.I.dvisor published
a Summary for RVMD with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RVMD($5.22B) has a higher market cap than ACAD($3B). RVMD YTD gains are higher at: 10.600 vs. ACAD (-41.872). ACAD has higher annual earnings (EBITDA): -67.83M vs. RVMD (-430.28M). RVMD has more cash in the bank: 1.85B vs. ACAD (439M). ACAD has less debt than RVMD: ACAD (57.2M) vs RVMD (87.9M). ACAD has higher revenues than RVMD: ACAD (726M) vs RVMD (11.6M).
ACADRVMDACAD / RVMD
Capitalization3B5.22B57%
EBITDA-67.83M-430.28M16%
Gain YTD-41.87210.600-395%
P/E RatioN/AN/A-
Revenue726M11.6M6,259%
Total Cash439M1.85B24%
Total Debt57.2M87.9M65%
FUNDAMENTALS RATINGS
ACAD: Fundamental Ratings
ACAD
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACADRVMD
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend about 1 month ago
77%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
ACADDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RVMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
REAI19.780.51
+2.64%
Intelligent Real Estate ETF
DDIV33.780.51
+1.54%
First Trust Dorsey Wright Momt & Div ETF
IBTE23.940.01
+0.04%
iShares iBonds Dec 2024 Term Tr ETF
KLIP14.50N/A
N/A
KraneShares China InternetAndCovCllStETF
HPS15.27-0.09
-0.59%
John Hancock Preferred Income Fund III

ACAD and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACAD has been loosely correlated with VRTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ACAD jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACAD
1D Price
Change %
ACAD100%
+2.30%
VRTX - ACAD
42%
Loosely correlated
-0.23%
DNLI - ACAD
41%
Loosely correlated
+4.48%
STTK - ACAD
40%
Loosely correlated
+1.24%
FOLD - ACAD
40%
Loosely correlated
+3.85%
VRDN - ACAD
39%
Loosely correlated
+0.81%
More